The Globe and Mail reports in its Tuesday, Oct. 29, edition that CIBC World Markets analyst Hamir Patel is keeping his "neutral" recommendation for Winpak intact. The Globe's Darcy Keith writes in the Eye On Equities column that Mr. Patel bumped his share target ahead by a loonie to $54. Analysts on average target the shares at $53.67. The Globe says Mr. Patel has modestly raised his estimates on the packaging company. Mr. Patel says in a note: "While we see higher returns among some of our other packaging names under coverage over the next 12 months, we note that Winpak is trading at only 6.5 times 2025E EV/EBITDA, a discount to its five-year average forward multiple of 7.9 times. At the same time, with more realistic vendor expectations, we see potential for the company to complete an acquisition in healthcare packaging next year. ... In the event the Republicans win the U.S. presidential election on Nov. 5, we see risks for Winpak if a second Trump administration were to impose about 10-per-cent tariffs on all imports in 2025. With so much of its capacity situated in Canada that sells into the U.S. (and not easily movable), we estimate such tariffs may represent about a $35-million hit to annual EBITDA."